— Know what they know.
Not Investment Advice

ACH NYSE

Accendra Health, Inc.
1W: -28.8% 1M: -56.9% 3M: -86.2% YTD: -78.3% 1Y: -95.6% 3Y: -89.9% 5Y: -96.2%
$0.51
-0.05 (-9.43%)
 
Weekly Expected Move ±10.1%
$0 $0 $1 $1 $1
NYSE · Healthcare · Medical - Distribution · Tech Score Strong Sell · Power 24 · $38.7M mcap · 56M float · 2.07% daily turnover · Short 62% of daily vol

Supply Chain Overview

13 relationships
13
As Filer
counterparties named
0
As Counterparty
mentioned by others
4
Rel. Types
2022-01-10
Earliest Filing
2025-12-31
Latest Filing
acquirer: 4 target: 4 partner: 4 investor: 1

Counterparties (Filed by ACH)

13 relationships

Companies named in ACH's SEC 8-K filings as business counterparties.

Counterparty Ticker Relationship Summary Filing Date SEC
Dominion Healthcare Acquisition Corporation — acquirer Purchaser of the Company's P&HS business 2025-12-31 View
Dominion Healthcare Holdings, L.P. — acquirer Purchaser Parent acquiring the Company's P&HS business 2025-12-31 View
Dominion Healthcare Acquisition Corporation — acquirer Acquired the Products & Healthcare Services business of Owens & Minor, Inc. for $375 million in cash and rollover units. 2025-10-07 View
Dominion Healthcare Holdings, L.P. — investor Parent entity of the Purchaser that received rollover units in exchange for O&M PHS LLC interests. 2025-10-07 View
Rotech Healthcare Holdings Inc. — target Target of terminated merger agreement; received $80M termination fee. 2025-06-05 View
Hitchcock Merger Sub Inc. — partner Wholly owned subsidiary of Owens & Minor, Inc. used as merger counterparty. 2025-06-05 View
Rotech Healthcare Holdings Inc. — target Target company in a merger agreement to be acquired by Owens & Minor, Inc. for $1.36 billion. 2024-07-23 View
Hitchcock Merger Sub Inc. — partner Wholly owned subsidiary of Owens & Minor, Inc. formed to merge with Rotech Healthcare Holdings Inc. 2024-07-23 View
Shareholder Representative Services LLC — partner Representative of the equity holders of Rotech Healthcare Holdings Inc. in the merger agreement. 2024-07-23 View
Apria, Inc. — target Target of acquisition via merger 2022-03-29 View
StoneOak Merger Sub Inc. — acquirer Wholly owned subsidiary used to acquire Apria, Inc. 2022-03-29 View
Apria, Inc. — target Target company in a merger agreement with Owens & Minor, Inc. 2022-01-10 View
StoneOak Merger Sub Inc. — partner Wholly owned subsidiary of Owens & Minor, Inc. used as the merger vehicle. 2022-01-10 View
Recent 8-K Filings (20)
Filing Date Description Type SEC
2026-09-28 Officer/Director Change; Exhibits View
2026-09-17 Officer/Director Change; Regulation FD; Other Events; Exhibits View
2026-08-17 Regulation FD; Exhibits View
2026-08-10 Officer/Director Change; Regulation FD; Exhibits View
2026-08-10 Earnings Release; Regulation FD; Exhibits View
2026-08-10 Material Agreement; Bylaws Amendment; Regulation FD; Exhibits Agreement View
2026-06-25 Other Events; Exhibits View
2026-06-15 Material Agreement; Financial Obligation; Other Events; Exhibits Agreement View
2026-05-22 Regulation FD; Exhibits View
2026-05-15 Officer/Director Change; Shareholder Vote View
2026-02-19 Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex View
2026-01-05 Financial Statements and Exhibits View
2025-12-31 Entry into Material Definitive Agreement; Completion of Acquisition or Disposition of Assets; Creati Agreement Acquisition View
2025-12-18 Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem View
2025-12-08 Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure View
2025-12-02 Regulation FD Disclosure; Financial Statements and Exhibits View
2025-10-30 Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex View
2025-10-07 Entry into Material Definitive Agreement; Regulation FD Disclosure; Financial Statements and Exhibit Agreement View
2025-09-19 Departure/Election of Directors; Appointment of Officers View
2025-08-11 Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms